ReproCELL Incorporated (TYO:4978)
Japan
· Delayed Price · Currency is JPY 168.00
+7.00 (4.35%)
May 30, 2025, 3:30 PM JST
ReproCELL Income Statement
Financials in millions JPY. Fiscal year is April - March.
Millions JPY. Fiscal year is Apr - Mar.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2016 - 2020 |
|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | 2016 - 2020 |
| Operating Revenue | 2,977 | 2,426 | 2,953 | 2,234 | 1,285 | Upgrade
|
| Other Revenue | 1 | - | - | - | 1 | Upgrade
|
| Revenue | 2,978 | 2,426 | 2,953 | 2,234 | 1,286 | Upgrade
|
| Revenue Growth (YoY) | 22.75% | -17.85% | 32.18% | 73.72% | 7.26% | Upgrade
|
| Cost of Revenue | 1,330 | 1,306 | 1,812 | 1,431 | 804 | Upgrade
|
| Gross Profit | 1,648 | 1,120 | 1,141 | 803 | 482 | Upgrade
|
| Selling, General & Admin | 1,243 | 1,129 | 984 | 895 | 836 | Upgrade
|
| Research & Development | 536 | 384 | 501 | 535 | 662 | Upgrade
|
| Operating Expenses | 1,779 | 1,530 | 1,497 | 1,450 | 1,530 | Upgrade
|
| Operating Income | -131 | -410 | -356 | -647 | -1,048 | Upgrade
|
| Interest & Investment Income | 67 | 51 | 88 | 9 | 42 | Upgrade
|
| Earnings From Equity Investments | -20 | -3 | -3 | -54 | -49 | Upgrade
|
| Currency Exchange Gain (Loss) | 17 | 88 | 21 | 20 | 45 | Upgrade
|
| Other Non Operating Income (Expenses) | 112 | 314 | 129 | 164 | 221 | Upgrade
|
| EBT Excluding Unusual Items | 45 | 40 | -121 | -508 | -789 | Upgrade
|
| Gain (Loss) on Sale of Investments | - | -9 | -52 | - | - | Upgrade
|
| Asset Writedown | - | -55 | -131 | -66 | -23 | Upgrade
|
| Other Unusual Items | - | -5 | - | - | - | Upgrade
|
| Pretax Income | 45 | -29 | -304 | -574 | -812 | Upgrade
|
| Income Tax Expense | -58 | 2 | 1 | 1 | 1 | Upgrade
|
| Earnings From Continuing Operations | 103 | -31 | -305 | -575 | -813 | Upgrade
|
| Minority Interest in Earnings | - | - | - | - | 1 | Upgrade
|
| Net Income | 103 | -31 | -305 | -575 | -812 | Upgrade
|
| Net Income to Common | 103 | -31 | -305 | -575 | -812 | Upgrade
|
| Shares Outstanding (Basic) | 93 | 86 | 84 | 76 | 71 | Upgrade
|
| Shares Outstanding (Diluted) | 93 | 86 | 84 | 76 | 71 | Upgrade
|
| Shares Change (YoY) | 8.45% | 1.65% | 10.90% | 6.32% | 0.24% | Upgrade
|
| EPS (Basic) | 1.11 | -0.36 | -3.62 | -7.57 | -11.37 | Upgrade
|
| EPS (Diluted) | 1.11 | -0.36 | -3.62 | -7.57 | -11.37 | Upgrade
|
| Free Cash Flow | -80 | -182 | -291 | -290 | -708 | Upgrade
|
| Free Cash Flow Per Share | -0.86 | -2.13 | -3.46 | -3.82 | -9.91 | Upgrade
|
| Gross Margin | 55.34% | 46.17% | 38.64% | 35.94% | 37.48% | Upgrade
|
| Operating Margin | -4.40% | -16.90% | -12.06% | -28.96% | -81.49% | Upgrade
|
| Profit Margin | 3.46% | -1.28% | -10.33% | -25.74% | -63.14% | Upgrade
|
| Free Cash Flow Margin | -2.69% | -7.50% | -9.85% | -12.98% | -55.05% | Upgrade
|
| EBITDA | -82 | -374 | -308 | -588 | -964 | Upgrade
|
| EBITDA Margin | -2.75% | -15.42% | -10.43% | -26.32% | -74.96% | Upgrade
|
| D&A For EBITDA | 49 | 36 | 48 | 59 | 84 | Upgrade
|
| EBIT | -131 | -410 | -356 | -647 | -1,048 | Upgrade
|
| EBIT Margin | -4.40% | -16.90% | -12.06% | -28.96% | -81.49% | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.